Document Detail

Bone disorder and vitamin D after gastric cancer surgery.
MedLine Citation:
PMID:  17708309     Owner:  NLM     Status:  MEDLINE    
BACKGROUND/AIMS: The present study was conducted to investigate the relationship between bone metabolic disorder after gastrectomy for gastric cancer and vitamin D metabolites or the hormones involved in calcium metabolism. METHODOLOGY: Twenty-one patients who had undergone gastrectomy for gastric cancer and had been followed for less than 10 years were assessed for bone disorder by microdensitometry. The levels of 1,25-dihydroxy vitamin D (1,25(OH)2VD), 25-hydroxy vitamin D (25(OH)VD), 24,25-dihydroxy vitamin D (24,25(OH)2VD), N-PTH, calcitonin, estradiol, osteocalcin, and ALP were measured and assessed for correlations with clinicopathological factors, including the operative procedure and the number of years since surgery. RESULTS: Bone disorder was found in 9 out of 21 patients (42.9%). The prevalence was significantly higher in patients who had undergone surgery more than 2 years before assessment, so there was a relationship between the period after surgery and bone disorder. Among the vitamin D metabolites, the level of 1,25(OH)2VD was normal in all patients, whereas 25(OH)VD was reduced in 6 out of 21 patients (28.6%) and 24,25(OH)2VD was reduced in 17 patients (81.0%). The 1,25(OH)2VD was significantly higher in the patients with Grade I to III bone disorder compared to the patients with normal bones or early bone disease. The 1,25(OH)2VD/25(OH)VD ratio was significantly higher in the patients without passage of food through the duodenum due to the reconstructive method, while the 25(OH)VD/24,25(OH)2VD ratio was significantly higher in the patients with remaining of duodenal food passage. PTH was decreased in about 50% of the patients, while calcitonin was normal in all patients. Estradiol was decreased in one female patient, while it was elevated in 10 of the 17 men (58.8%). The osteocalcin level was high in all patients irrespective of the period after surgery. CONCLUSIONS: After gastrectomy, the incidence of bone metabolic disorder increases with time. Changes of vitamin D metabolites, particularly 25(OH)VD and 24,25(OH)2VD, seem to be closely associated with post-gastrectomy bone disease.
Yasushi Rino; Yoshinori Takanashi; Yuji Yamamoto; Daisuke Inagaki; Masakazu Kawamoto; Hiroshi Harada; Akio Ashida; Hiroo Wada; Roppei Yamada; Takashi Ohshima; Shinsuke Hatori; Toshio Imada
Related Documents :
9355669 - Juvenile chronic arthritis--bone mineral density in relation to corticosteroid therapy.
21431299 - Diagnostic accuracy of 64-slice computed tomography coronary angiography in a large pop...
7582699 - Aetiology and presenting symptoms in male osteoporosis.
20557749 - Focal cement accumulation in lytic metastatic lesions: a new sign in vertebroplasty?
24488839 - Diamine oxidase activity levels in anorexia nervosa.
4095249 - Hypovitaminosis d and response to supplementation in older patients with cystic fibrosis.
7298049 - Drug related myocarditis. i. hypersensitivity myocarditis.
1395659 - Hypothermia in the sepsis syndrome and clinical outcome. the methylprednisolone severe ...
4025689 - Effect of plasma mebendazole concentrations in the treatment of human echinococcosis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hepato-gastroenterology     Volume:  54     ISSN:  0172-6390     ISO Abbreviation:  Hepatogastroenterology     Publication Date:    2007 Jul-Aug
Date Detail:
Created Date:  2007-08-21     Completed Date:  2007-12-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8007849     Medline TA:  Hepatogastroenterology     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  1596-600     Citation Subset:  IM    
Department of Surgery, Yokohama City University, Kanagawa, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Bone Diseases, Metabolic / etiology*,  metabolism*
Gastrectomy / adverse effects*
Middle Aged
Stomach Neoplasms / surgery*
Vitamin D / metabolism*
Reg. No./Substance:
1406-16-2/Vitamin D

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients ...
Next Document:  13C-urea breath test in patients having undergone total gastrectomy.